Lymphocyte detection for cancer analysis using a novel fusion block based channel boosted CNN

Zunaira Rauf1,2, Abdul Rehman Khan1, Anabia Sohail1,3

  • 1Pattern Recognition Lab, Department of Computer and Information Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan.

Scientific Reports
|August 28, 2023
PubMed

Insights

A new AI model, BCF-Lym-Detector, accurately detects tumor-infiltrating lymphocytes (TILs) in cancer histology images. This automated approach improves upon manual analysis, aiding pathologists in cancer diagnosis.

Area of Science:

  • Computational pathology
  • Artificial intelligence in oncology
  • Biomarker discovery

Background:

  • Tumor-infiltrating lymphocytes (TILs) are crucial biomarkers in cancer analysis.
  • Automated detection of TILs is difficult due to their varied appearance and image artifacts.

Purpose of the Study:

  • To develop a novel Boosted Channels Fusion-based CNN (BCF-Lym-Detector) for accurate lymphocyte detection in diverse cancer histology images.
  • To enhance the feature learning capacity for improved TIL identification.

Main Methods:

  • Proposed a two-stage detection network: tissue-level candidate region selection followed by cellular-level detection.
  • Developed a novel adaptive fusion block to integrate and select optimal features from multiple CNN architectures.
  • Utilized multi-level feature learning to preserve spatial information and detect lymphocytes with varying morphologies.

Main Results:

  • Achieved high F-scores of 0.93 on LYSTO and 0.84 on NuClick datasets.
  • Demonstrated strong generalization on unseen data with a recall of 0.75 and an F-score of 0.73.
  • The BCF-Lym-Detector showed substantial improvements due to diverse feature extraction and dynamic feature selection.

Conclusions:

  • The BCF-Lym-Detector significantly enhances automated TIL detection in digital pathology.
  • The proposed method offers a promising tool to assist pathologists, improving diagnostic accuracy and efficiency.
  • This AI-driven approach holds potential for advancing cancer biomarker analysis.

Related Concept Videos